Ratings DSM-Firmenich

Equities

DSFIR

CH1216478797

Consumer Goods Conglomerates

End-of-day quote Euronext Amsterdam Other stock markets 2024-11-29			5-day change	1st Jan Change
103.95 ^CHF	+0.19%		-3.08%	+12.99%

11-21	Robertet: Fonds Stratégique de Participations tops 5% mark	CF
11-21	DSM-Firmenich Exits Stake in Fragrances, Flavors Company Robertet	MT

Highlights: DSM-Firmenich

Sales forecast by analysts have been recently revised upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses: DSM-Firmenich

The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
With an expected P/E ratio at 59.4 and 35 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company is highly valued given the cash flows generated by its activity.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings Chart: DSM-Firmenich

Source: Surperformance

Sector Comparison:

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	Capi. ($)
DSM-FIRMENICH		29.1B
BERKSHIRE HATHAWAY INC.	-	1,041B
HONEYWELL INTERNATIONAL INC.		151B
ILLINOIS TOOL WORKS INC.		81.95B
3M COMPANY		72.71B
MITSUBISHI HEAVY INDUSTRIES, LTD.		49.1B
MITSUBISHI ELECTRIC CORPORATION		35.12B
INDUSTRIES QATAR Q.P.S.C.		21.57B
Average		185.29B
Weighted average by Cap.

See all sector ratings

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes